Ignite Creation Date:
2025-12-24 @ 9:54 PM
Ignite Modification Date:
2025-12-31 @ 4:45 AM
Study NCT ID:
NCT00077532
Status:
COMPLETED
Last Update Posted:
2012-06-22
First Post:
2004-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma
Sponsor:
National Institutes of Health Clinical Center (CC)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-03
Start Date Type:
None
Primary Completion Date:
2007-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-02
Completion Date Type:
ACTUAL
First Submit Date:
2004-02-10
First Submit QC Date:
None
Study First Post Date:
2004-02-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-06-21
Last Update Post Date:
2012-06-22
Last Update Post Date Type:
ESTIMATED